Genetic polymorphisms and kidney transplant outcomes

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):605-10. doi: 10.1097/MNH.0000000000000068.

Abstract

Purpose of review: Gene polymorphism studies are growing at a quasiexponential rate and aim to improve immediate and long-term outcomes in renal transplantation. This review highlights recent evidence and potential future directions for genetic research studies.

Recent findings: Studies are largely based on immunity, inflammation and pharmacogenetics, investigating mostly 'surrogate' outcomes with sometimes conflicting results. However, the last 12 months has also heralded the emergence of important genome-wide association studies on transplantation, more robust replicated multicentre analyses of candidate gene variants, meta-analyses, and an increasing interest in copy number variation and donor genetics.

Summary: These studies set the scene for further investigation, aiming to understand pathways of disease and biomarkers of risk, and are leading to a greater understanding of the biology of transplantation. Future studies will require focus on donor : recipient and gene : environment interactions, and an integrated approach of 'transplantomics' to evaluate long-term outcomes in multinational collaborations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Genetic Markers
  • Genotype
  • Graft Rejection / genetics*
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Graft Survival / genetics
  • Humans
  • Immunity, Innate / genetics
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / pharmacokinetics
  • Kidney Transplantation* / adverse effects
  • Pharmacogenetics
  • Phenotype
  • Polymorphism, Genetic*
  • Risk Assessment
  • Risk Factors
  • T-Lymphocytes / immunology
  • Treatment Outcome

Substances

  • Genetic Markers
  • Immunosuppressive Agents